Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
177
NCT00579423
Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
Phase: Phase 2
Role: Collaborator
Start: Nov 30, 2000
Completion: Mar 31, 2009
NCT04828304
PLASOMA Ultimate Safety & Efficacy Study
Phase: N/A
Role: Lead Sponsor
Start: May 26, 2021
Completion: Dec 16, 2024
NCT04922463
PLASOMA Efficacy & Technology Health (PETH) Study
Start: Jun 1, 2021
Completion: Apr 20, 2023